Friday 6 November 2026
Export PNTG’s income statement to Excel — free account
The Pennant Group, Inc.
PNTG Healthcare Medical Care Facilities
The Pennant Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $947.7 million, up 36.3% from fiscal 2024.
- Revenue
- +32.0%
- EPS
- +55.6%
- Free cash flow
- −3.19%
- Total debt
- +662.8%
Quarter to September 2026, against a year earlier
36.58
3.42
−8.55%
Follow PNTG
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 4 Nov | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
6 | 6 | 5 | 6 |
| 8.62% | 8.51% | 8.76% | 9.41% | ||
| 3.59% | 3.57% | 3.61% | 3.99% | ||
ROIC |
6.11% | 6.38% | 6.63% | 7.14% | |
Return on Tangible Assets |
36.46% | 34.37% | 30.35% | 29.72% | |
Average Days of Receivables |
47.41 | 43.81 | 44.12 | 40.65 | |
Free Cash Flow per Share |
1.05 | 1.46 | 1.00 | 0.98 | |
Free Cash Flow |
36.26 | 50.77 | 34.68 | 34.35 | |
Capital Expenditures |
(12.04) | (15.35) | (18.62) | (30.15) | |
| Other line items | |||||
Cash ROIC |
6.42% | 9.00% | 5.62% | 5.40% | |
Accounts Receivable Turnover |
9.27 | 9.40 | 9.63 | 10.36 | |
Accounts Payable Turnover |
37.22 | 42.43 | 41.77 | 41.24 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
11.24 | 9.43 | 10.09 | 9.91 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.26) | (0.26) | (0.27) | (0.26) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
7.50% | 7.42% | 7.26% | 6.92% | |
Share Based Compensation of Revenue |
0.94% | 0.91% | 0.91% | 0.93% | |
Interest Coverage |
7.77 | 6.62 | 5.82 | 5.15 | |
Operating CF/Net income |
1.63 | 2.18 | 1.65 | 1.80 | |
Depreciation/Fixed assets |
0.15 | 0.16 | 0.15 | 0.14 | |
Capex/Depreciation |
(1.28) | (1.50) | (1.66) | (2.34) | |
Revenue per Share |
27.42 | 29.47 | 31.63 | 33.57 | |
Operating CF per Share |
1.40 | 1.90 | 1.53 | 1.84 | |
Capex per Share |
(0.35) | (0.44) | (0.53) | (0.86) | |
Capex to Sales |
0.01 | 0.02 | 0.02 | 0.03 |
Columns are period end dates · fundamentals updated 4 Nov 2026